Spots Global Cancer Trial Database for acute lymphocytic leukemia (all)
Every month we try and update this database with for acute lymphocytic leukemia (all) cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Study to Assess Safety, Tolerability, Pharmacokinetics and Antitumor Activity of AZD4573 in Relapsed/Refractory Haematological Malignancies | NCT03263637 | Relapsed or Ref... Acute Myeloid L... Acute Lymphocyt... Chronic Lymphoc... High Risk Myelo... Chronic Myelomo... Richter's Syndr... B-cell Non-Hodg... T-cell Non-Hodg... Small Lymphocyt... Multiple Myelom... | AZD4573 | 18 Years - 130 Years | AstraZeneca | |
| A Study of Low-Dose Decitabine in Relapsed or Refractory Acute Lymphocytic Leukemia (ALL) | NCT00349596 | Acute Lymphocyt... | Decitabine | - | M.D. Anderson Cancer Center | |
| Expanded Access to Navitoclax | NCT03592576 | Myelofibrosis Acute Lymphocyt... Lymphoblastic L... | Navitoclax Venetoclax | 4 Years - | AbbVie | |
| A Single-arm Safety Study of Transplantation Using Umbilical Cord Blood and Human Placental-derived Stem Cells From Partially Matched Related Donors in Persons With Certain Malignant Blood Diseases and Non-malignant Disorders | NCT00596999 | Hematologic Mal... | UCB and HPDSC | - 55 Years | Celgene | |
| Allo BMT Using Matched Related/Unrelated Donors With FluBu and HiCY | NCT00809276 | Lymphoma Multiple Myelom... Leukemia Myelodysplastic... | Busulfan, Fluda... | - 65 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Thymoglobulin to Prevent Acute Graft vs. Host Disease (GvHD) in Patients With Acute Lymphocytic Leukemia (ALL) or Acute Myelogenous Leukemia (AML) Receiving a Stem Cell Transplant | NCT00088543 | Acute Myelogeno... Acute Lymphocyt... Graft vs. Host ... | Thymoglobulin [... Thymoglobulin [... | 18 Years - 55 Years | Sanofi | |
| Study of the Glutaminase Inhibitor CB-839 in Leukemia | NCT02071927 | Acute Myeloid L... Acute Lymphocyt... | CB-839 CB-Aza | 18 Years - | Calithera Biosciences, Inc | |
| Oral Histone Deacetylase Inhibitor 4SC-202 in Patients With Advanced Hematologic Malignancies (TOPAS) | NCT01344707 | Advanced Hemato... | 4SC-202 | 18 Years - | 4SC AG | |
| A Study of Low-Dose Decitabine in Relapsed or Refractory Acute Lymphocytic Leukemia (ALL) | NCT00349596 | Acute Lymphocyt... | Decitabine | - | M.D. Anderson Cancer Center | |
| Phase 1 Study of Terameprocol (EM-1421) in Patients With Leukemia | NCT00664677 | Leukemias Acute Myeloid L... Acute Lymphocyt... Adult T Cell Le... Chronic Myeloid... Chronic Lymphoc... Myelodysplastic... Chronic Myelomo... | Terameprocol (E... | 18 Years - | Erimos Pharmaceuticals | |
| Thymoglobulin to Prevent Acute Graft vs. Host Disease (GvHD) in Patients With Acute Lymphocytic Leukemia (ALL) or Acute Myelogenous Leukemia (AML) Receiving a Stem Cell Transplant | NCT00088543 | Acute Myelogeno... Acute Lymphocyt... Graft vs. Host ... | Thymoglobulin [... Thymoglobulin [... | 18 Years - 55 Years | Sanofi | |
| A Study to Evaluate the Effect of Weekly PROCRIT (Epoetin Alfa) or Placebo on Anemia and Quality of Life in Children With Cancer Undergoing Chemotherapy | NCT00261677 | Anemia Hodgkin Disease Leukemia Lymphoma, Non-h... | epoetin alfa | 5 Years - 18 Years | Ortho Biotech Products, L.P. | |
| Red Cell Transfusion Goals in Patients With Acute Leukemias | NCT02086773 | Acute Lymphobla... Acute Lymphocyt... Acute Myelogeno... Acute Promyeloc... | Red blood cell ... | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Study of the Glutaminase Inhibitor CB-839 in Leukemia | NCT02071927 | Acute Myeloid L... Acute Lymphocyt... | CB-839 CB-Aza | 18 Years - | Calithera Biosciences, Inc | |
| A Single-arm Safety Study of Transplantation Using Umbilical Cord Blood and Human Placental-derived Stem Cells From Partially Matched Related Donors in Persons With Certain Malignant Blood Diseases and Non-malignant Disorders | NCT00596999 | Hematologic Mal... | UCB and HPDSC | - 55 Years | Celgene | |
| Red Cell Transfusion Goals in Patients With Acute Leukemias | NCT02086773 | Acute Lymphobla... Acute Lymphocyt... Acute Myelogeno... Acute Promyeloc... | Red blood cell ... | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases | NCT01962636 | Acute Myeloid L... Acute Lymphocyt... Chronic Myeloge... Plasma Cell Leu... Myelofibrosis Myelodysplasia Chronic Lymphoc... Small Lymphocyt... Marginal Zone B... Follicular Lymp... Lymphoplasmacyt... Mantle-Cell Lym... Prolymphocytic ... Diffuse Large B... Lymphoblastic L... Burkitt's Lymph... Non-Hodgkin Lym... Multiple Myelom... | Fludarabine Cyclophosphamid... Total Body Irra... Cyclosporine A Mycophenylate m... Umbilical cord ... | - 55 Years | Masonic Cancer Center, University of Minnesota | |
| Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases | NCT01962636 | Acute Myeloid L... Acute Lymphocyt... Chronic Myeloge... Plasma Cell Leu... Myelofibrosis Myelodysplasia Chronic Lymphoc... Small Lymphocyt... Marginal Zone B... Follicular Lymp... Lymphoplasmacyt... Mantle-Cell Lym... Prolymphocytic ... Diffuse Large B... Lymphoblastic L... Burkitt's Lymph... Non-Hodgkin Lym... Multiple Myelom... | Fludarabine Cyclophosphamid... Total Body Irra... Cyclosporine A Mycophenylate m... Umbilical cord ... | - 55 Years | Masonic Cancer Center, University of Minnesota | |
| Unrelated Umbilical Cord Blood (UBC)Transplantation | NCT01768845 | Chronic Myeloge... Acute Myelogeno... Myelodysplastic... Multiple Myelom... Hodgkin Lymphom... Non-Hodgkin Lym... Chronic Lymphoc... Acute Lymphocyt... Severe Aplastic... | umbilical cord ... | 16 Years - 70 Years | West Virginia University | |
| Thymoglobulin to Prevent Acute Graft vs. Host Disease (GvHD) in Patients With Acute Lymphocytic Leukemia (ALL) or Acute Myelogenous Leukemia (AML) Receiving a Stem Cell Transplant | NCT00088543 | Acute Myelogeno... Acute Lymphocyt... Graft vs. Host ... | Thymoglobulin [... Thymoglobulin [... | 18 Years - 55 Years | Sanofi |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
